Topical treatment of infections, tumors and hyperkeratotic disorders

被引：1

作者：

Messerschmidt, A. ^{[1
]}

Schultheis, K. ^{[1
]}

Ochsendorf, F. ^{[1
]}

机构：

[1] Univ Frankfurt Klinikum, Klin Dermatol Venerol & Allergol, D-60590 Frankfurt, Germany

来源：

HAUTARZT | 2014年 / 65卷 / 03期

关键词：

Topical anti-infective compounds; Scabies; Pediculosis; Actinic keratosis; Indication; ACTINIC KERATOSES; CONTROLLED-TRIALS; GEL; 2.5-PERCENT;

D O I：

10.1007/s00105-013-2741-8

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

In this review substances for the topical treatment of skin infections, skin tumors and hyperkeratotic disorders are presented. Substances with specific actions as topical antimycotic, antibiotic, antiseptic, antiviral and antiparasitic agents as well as diclofenac in hyaluronic acid, 5-fluoruracil, imiquimod, ingenol mebutate, bexarotene, mechlorethamine, BCNU, alitretinoin, silicone gel, salicylic acid and urea are discussed with respect to their mode of action, indication and side effects.

引用

页码：207 / 217

页数：11

共 18 条

[1] Effectiveness of 5-fluorouracil treatment for actinic keratosis - a systematic review of randomized controlled trials [J].

Askew, Deborah A. ;

Mickan, Sharon M. ;

Soyer, Peter ;

Wilkinson, David .

INTERNATIONAL JOURNAL OF DERMATOLOGY, 2009, 48 (05) :453-463

[2] Keloid and hypertrophic scar treatment modalities. An update [J].

Branski, L. K. ;

Rennekampff, H. O. ;

Vogt, P. M. .

CHIRURG, 2012, 83 (09) :831-844

[3] Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel - Results of phase 1 and 2 trials [J].

Duvic, M ;

Friedman-Kien, AE ;

Looney, DJ ;

Miles, SA ;

Myskowski, PL ;

Scadden, DT ;

Von Roenn, J ;

Galpin, JE ;

Groopman, J ;

Loewen, G ;

Stevens, V ;

Truglia, JA ;

Yocum, RC .

ARCHIVES OF DERMATOLOGY, 2000, 136 (12) :1461-1469

[4] Human herpes simplex virus infections: Epidemiology, pathogenesis, symptomatology, diagnosis, and management [J].

Fatahzadeh, Mahnaz ;

Schwartz, Robert A. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 57 (05) :737-763

[5]

Garbe C, 2005, DERMATOLOGISCHE REZE

[6]

Gross G, 2001, HAUTARZT, V52, P405, DOI 10.1007/s001050051333

[7] Scabies [J].

Hafner, C. .

HAUTARZT, 2009, 60 (02) :145-159

[8] Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: Results of two placebo-controlled studies of daily application to the face and balding scalp for two 3-week cycles [J].

Hanke, C. William ;

Beer, Kenneth R. ;

Stockfleth, Eggert ;

Wu, Jason ;

Rosen, Theodore ;

Levy, Sharon .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (04) :573-581

[9]

Korting HC, 2002, DIAGNOSTISCHE THERAP

[10] Imiquimod 5% cream for the treatment of actinic keratosis: Results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials [J].

Lebwohl, M ;

Dinehart, MB ;

Whiting, D ;

Lee, PK ;

Tawfik, N ;

Jorizzo, J ;

Lee, JH ;

Fox, TL .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (05) :714-721

← 1 2 →